市場調查報告書

癌症或腫瘤分析 : 市場機會分析及未來預測

Global Cancer or Tumor Profiling Market Size study, By Technology, By Cancer Type, By Applications and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 888141
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
癌症或腫瘤分析 : 市場機會分析及未來預測 Global Cancer or Tumor Profiling Market Size study, By Technology, By Cancer Type, By Applications and Regional Forecasts 2019-2026
出版日期: 2019年07月10日內容資訊: 英文
簡介

全球癌症或腫瘤分析市場在2017年估算為58億7,000萬美金。預測今後在2019年∼2026年間將以10.74%以上的年複合成長率擴大。

本報告提供癌症或腫瘤分析的世界市場調查,市場概要,各類型,用途,地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 主要的趨勢
  • 全球的及各分類市場預測,2016年-2026年(10億美元)
    • 各技術,2016年-2026年(10億美元)
    • 各類型,2016年-2026年(10億美元)
    • 各用途,2016年-2026年(10億美元)
    • 各地區,2016年-2026年(10億美元)
  • 預測方法
  • 調查的前提條件

第2章 市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 產業的演進
    • 調查範圍
  • 調查期間
  • 貨幣換算比率

第3章 市場動態

  • Seesaw分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 市場產業分析

  • 五力分析模型
    • 買方議價能力
    • 供應商談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭情形
    • 對五力分析模型的未來方法
  • PEST分析
    • 政治方案
    • 經濟方案
    • 社會方案
    • 技術方案
  • 主要的購買標準(按需)
  • 法律規範(按需)
  • 投資/引進方案(按需)
  • 分析師的建議與結論

第5章 癌症或腫瘤分析市場:各技術

  • 市場概述
  • 市場效能 - 潛在模式
  • 子區隔分析
    • 免疫測量
    • 雜合反應
    • 下一代序列
    • 質譜分析
    • 其他

第6章 癌症或腫瘤分析市場:各類型

  • 市場概述
  • 市場效能 - 潛在模式
  • 子區隔分析
    • 肺癌
    • 乳癌
    • 大腸癌
    • 前列腺癌
    • 黑色素瘤癌
    • 其他

第7章 癌症或腫瘤分析市場:各用途

  • 市場概述
  • 市場效能 - 潛在模式
  • 子區隔分析
    • 臨床
    • 研究

第8章 癌症或腫瘤分析市場:各地區

  • 地區市場概述(2016-2026)
  • 北美市場概述
    • 美國
    • 加拿大
  • 歐洲市場概述
    • 英國
    • 德國
    • 其他
  • 亞洲市場概述
    • 中國
    • 印度
    • 日本
    • 其他
  • 中南美市場概述
    • 巴西
    • 墨西哥
  • 其他
    • 南美
    • 中東、非洲

第9章 其他競爭公司的資訊

  • 企業的市場佔有率(資料的各可得性)
  • 尖端市場策略
  • 企業簡介
    • Illumina, Inc.
    • Qiagen N.V.
    • Neogenomics Laboratories, Inc.
    • HTG Molecular Diagnostics, Inc.
    • Genomic Health Inc.
    • Caris Life Sciences
    • Helomics Corporation
    • Nanostring Technologies, Inc.
    • Oxford Gene Technology
    • Ribomed Biotechnologies, Inc.

第10章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
    • 調查的前提條件
目錄

Global Cancer or Tumor Profiling Market is valued approximately USD 5.87 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.74% over the forecast period 2019-2026. Growing focus for the development of personalized medicine, growing utility of biomarkers in tumor profiling and increasing R&D investments in cancer are some major trends that are responsible for the wide adoption of Cancer or Tumor Profiling globally. The market is majorly driven by increasing prevalence of cancer globally. The World Cancer Research Fund International (WCRFI) estimates that, nearly 2 million new cases of breast cancer are being detected every year and breast cancer is considered as the most common form of cancer in women globally. American Cancer Research Society (ACRS) anticipates by 2030, incident rate of breast cancer is expected to reach over 9.9million cases with over 5.5million annual deaths, primarily due to aging population. Incident rates of breast cancer are highest (46% in 2016) amongst women aged between 45-65 years across the globe. ACRS studies reveals that, with aging population prevalence rate of breast cancer amongst elderly women aged 55 years and above is bound to increase. Breast cancer represents 12% of all new cases of cancer amongst women in 2016, according to WCRFI. Europe leads the world with highest number (25% in 2016) of new breast cancer cases in the world followed by North America and Asia Pacific according to National Cancer Institute (NCI), USA. Belgium, Denmark, France, Netherlands, Bahamas and USA are countries with highest rates of breast cancer in the world according to WCRFI survey in 2016. Global economic burden due to breast cancer stood at $5.7 billion in 2016 according to ACRS. However, ACRS estimates, the economic burden on breast cancer is anticipated to reach over $8 billion by 2025. Increasing number of breast cancer cases would supplement global Cancer or Tumor profiling market for the forecasted period. However, lack of skilled professionals is a major factor that impede the growth of the Cancer or Tumor Profiling market over the forecast period.

On the basis of segmentation, the Cancer or Tumor Profiling market is segmented into technology, cancer type and application. The technology segment of global Cancer or Tumor Profiling market is classified into immunoassays, hybridization, next generation sequencing, mass spectrometry and other technologies of which immunoassays accounted for the largest market share owing to its cost-effectiveness, high sensitivity as well as technological advancements in this technology would propel the growth of the immunoassays. Based on the cancer type segment, the Cancer or Tumor profiling is bifurcated into breast cancer, lung cancer, prostate cancer, colorectal cancer, melanoma cancer and other cancer of which breast cancer segment holds the leading position owing to the increased awareness about breast cancer diagnosis, rising prevalence of breast cancer. The application segment includes clinical application and research application.

The regional analysis of Cancer or Tumor Profiling Market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America have occupied major share in the global Cancer or Tumor Profiling market. The major reasons for the dominance of North America are rising prevalence of cancer along with the high rate of adoption in this region. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to rising number of contract research organizations (CROs), growing demand for better healthcare services and increasing incidences of cancer.

The leading market players mainly include-

  • Illumina, Inc.
  • Qiagen N.V.
  • Neogenomics Laboratories, Inc.
  • HTG Molecular Diagnostics, Inc.
  • Genomic Health Inc.
  • Caris Life Sciences
  • Helomics Corporation
  • Nanostring Technologies, Inc.
  • Oxford Gene Technology
  • Ribomed Biotechnologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

  • Immunoassays
  • Hybridization
  • Next Generation Sequencing
  • Mass Spectrometry
  • Other Technologies

By Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Melanoma Cancer
  • Others Cancer
  • By Application:
  • Clinical Application
  • Research Application

By Regions:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • ROAPEC
  • LAMEA
  • Brazil
  • Mexico
  • ROW
  • Middle East & Africa

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Cancer or Tumor Profiling Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Cancer or Tumor Profiling Market, by Technology, 2016-2026 (USD Billion)
    • 1.3.2. Cancer or Tumor Profiling Market, by Cancer Type, 2016-2026 (USD Billion)
    • 1.3.3. Cancer or Tumor Profiling Market, by Application, 2016-2026 (USD Billion)
    • 1.3.4. Cancer or Tumor Profiling Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Cancer or Tumor Profiling Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Cancer or Tumor Profiling Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Cancer or Tumor Profiling Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer/Tumour Profiling Market, By Technology

  • 5.1. Market Snapshot
  • 5.1. Market Performance - Potential Model
  • 5.2. Global Cancer/Tumour Profiling Market, Sub Segment Analysis
    • 5.2.1. Immunoassays
      • 5.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.2.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.2.2. Hybridization
      • 5.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.2.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.2.3. Next Generation Sequencing
      • 5.2.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.2.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.2.4. Mass Spectrometry
      • 5.2.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.2.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.2.5. Other Technologies
      • 5.2.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.2.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Global Cancer/Tumour Profiling Market, By Cancer Type

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Global Cancer/Tumour Profiling Market, Sub Segment Analysis
    • 6.3.1. Lung Cancer
      • 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.2. Breast Cancer
      • 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.3. Colorectal Cancer
      • 6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.4. Prostate Cancer
      • 6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.5. Melanoma Cancer
      • 6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.6. Other Cancers
      • 6.3.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Global Cancer/Tumour Profiling Market, By Application

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Global Cancer/Tumour Profiling Market, Sub Segment Analysis
    • 7.3.1. Clinical Application
      • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.3.2. Research Application
      • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Global Cancer/Tumour Profiling Market, by Regional Analysis

  • 8.1. Cancer/Tumour Profiling Market, Regional Market Snapshot (2016-2026)
  • 8.2. North America Cancer/Tumour Profiling Market Snapshot
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.3. Europe Cancer/Tumour Profiling Market Snapshot
    • 8.3.1. U.K.
      • 8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.3. Rest of Europe
      • 8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.4. Asia Cancer/Tumour Profiling Market Snapshot
    • 8.4.1. China
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.2. India
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.4. Rest of Asia Pacific
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.5. Latin America Cancer/Tumour Profiling Market Snapshot
    • 8.5.1. Brazil
      • 8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.5.2. Mexico
      • 8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.6. Rest of The World
    • 8.6.1. South America
      • 8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.6.2. Middle East and Africa
      • 8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Competitive Intelligence

  • 9.1. Company Market Share (Subject to Data Availability)
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Illumina, Inc.
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial (Subject to Data Availability)
      • 9.3.1.3. Product Summary
      • 9.3.1.4. Recent Developments
    • 9.3.2. Qiagen N.V.
    • 9.3.3. Neogenomics Laboratories, Inc.
    • 9.3.4. HTG Molecular Diagnostics, Inc.
    • 9.3.5. Genomic Health Inc.
    • 9.3.6. Caris Life Sciences
    • 9.3.7. Helomics Corporation
    • 9.3.8. Nanostring Technologies, Inc.
    • 9.3.9. Oxford Gene Technology
    • 9.3.10. Ribomed Biotechnologies, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
    • 10.1.6. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER OR TUMOR PROFILING MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER OR TUMOR PROFILING MARKET
  • TABLE 3. GLOBAL CANCER OR TUMOR PROFILING MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY CANCER TYPE 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, BY ELECTRIC VEHICLE, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 49. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 54. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 59. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 64. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 67. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 69. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 72. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 74. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 77. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 79. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 84. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 89. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 94. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 96. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 98. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 99. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 101. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 102. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 103. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 104. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 106. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 107. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL CANCER OR TUMOR PROFILING MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL CANCER OR TUMOR PROFILING MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL CANCER OR TUMOR PROFILING MARKET, KEY TRENDS 2017
  • FIG 5. GLOBAL HEAT EXCHANGERS, GROWTH PROSPECTS 2018-2026
  • FIG 6. GLOBAL CANCER OR TUMOR PROFILING MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL CANCER OR TUMOR PROFILING MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL CANCER OR TUMOR PROFILING MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. GLOBAL CANCER OR TUMOR PROFILING MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA CANCER OR TUMOR PROFILING MARKET 2016 & 2026 (USD BILLION)
  • FIG 33. EUROPE CANCER OR TUMOR PROFILING MARKET 2016 & 2026 (USD BILLION)
  • FIG 34. ASIA PACIFIC CANCER OR TUMOR PROFILING MARKET 2016 & 2026 (USD BILLION)
  • FIG 35. LATIN AMERICA CANCER OR TUMOR PROFILING MARKET 2016 & 2026 (USD BILLION)
  • FIG 36. GLOBAL CANCER OR TUMOR PROFILING MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
Back to Top